TELETRADER News
4/19, 4:03 PM (Source: TeleTrader)
more TeleTrader news

RDIF: Sputnik V has 97.6% efficacy on 3.8M administered shots

The Russian Direct Investment Fund (RDIF) announced on Monday that its coronavirus vaccine Sputnik V has demonstrated the efficacy of 97.6% based on 3.8 million Russian citizens who have received both doses. The infection rate among vaccinated adults was 0.027% starting from the 35th day from the date of the first injection, compared to 1.1% in the unvaccinated population.

"The actual efficacy of the Sputnik V vaccine may be even higher than the results of our analysis demonstrate since the data on the case registration system allows a time lag between the collection of the sample (the actual date of the disease) and the diagnosis. Sputnik V has once again confirmed its high effectiveness in the prevention of coronavirus infection," said Alexander Gintsburg, director of the Gamaleya Research Institute of Epidemiology and Microbiology, which developed the vaccine.

Breaking the News / DJ